Holen Sie sich die Stockscreener-App
127.87
1.71%
-2.22
Handel nachbörslich:
127.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$130.09
Offen:
$130
24-Stunden-Volumen:
426.44K
Relative Volume:
0.54
Marktkapitalisierung:
$5.66B
Einnahmen:
$2.81B
Nettoeinkommen (Verlust:
$-294.68M
KGV:
-5.6059
EPS:
-22.8098
Netto-Cashflow:
$232.59M
1W Leistung:
-5.80%
1M Leistung:
-1.42%
6M Leistung:
+2.40%
1J Leistung:
+5.58%
1-Tages-Spanne:
$126.55
$130.07
1-Wochen-Bereich:
$126.55
$136.59
52-Wochen-Spanne:
$100.18
$139.67
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
127.87 | 5.76B | 2.81B | -294.68M | 232.59M | -22.81 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-27 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-01-27 | Hochstufung | Needham | Hold → Buy |
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Teleflex Inc. 2026 Indenture: Key Covenants, Redemption Terms, and SEC Compliance for Senior Notes - Minichart
Teleflex Issues New Senior Notes to Strengthen Capital Structure - TipRanks
Teleflex issues $500 million in 5.875% senior notes due 2032 - Investing.com
Teleflex Issues $500 Million 5.875% Senior Notes Due 2032 Under New Indenture - TradingView
Teleflex Incorporated Issues $500,000,000 Senior Notes Due January 2032 - marketscreener.com
Teleflex (NYSE: TFX) sells $500M 5.875% senior notes due 2032 - Stock Titan
Teleflex Inc. Stock (US8793691069): Moody’s Ba2 rating and valuation in focus - AD HOC NEWS
How Teleflex Incorporated (TFX) Affects Rotational Strategy Timing - Stock Traders Daily
Teleflex Inc. Stock (US8793691069): Valuation metrics in focus for US investors - AD HOC NEWS
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Will Teleflex's (TFX) Note Refinancing and Freesolve Data Shift Its Acquisition-Led Innovation Narrative? - simplywall.st
Teleflex grants special RSU award to interim CEO - The Globe and Mail
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Assessing Teleflex (TFX) Valuation After Positive Four Year BIOMAG I Follow Up Data - Sahm
Teleflex Inc (TFX) Stock Up 3.0% and Still Undervalued -- GF Sco - GuruFocus
[Form 3] TELEFLEX INC Initial Statement of Beneficial Ownership - Stock Titan
Teleflex (TFX) CEO Jason Weidman receives new RSU and stock option grants - Stock Titan
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Teleflex (NYSE: TFX) grants $600,000 RSU to interim chief executive - Stock Titan
Teleflex Freesolve Data Underscores Cardiology Ambitions And Debt Refinancing Trade Off - Yahoo Finance
Teleflex unveils four-year data for Freesolve medical scaffold - grafa.com
Teleflex Says Study Shows No New Cardiac Events at 4 Years for Freesolve Scaffold - marketscreener.com
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G) - Business Wire
Teleflex Q1 2026 Earnings: EPS Surprises to the Upside; Stock Slips Despite BeatTech Earnings Analysis - newsline.com
Piper Sandler Initiates Teleflex(TFX.US) With Buy Rating, Announces Target Price $160 - Moomoo
Piper Sandler upgrades Teleflex stock rating on synergy potential By Investing.com - Investing.com India
Teleflex Incorporated (TFX) Stock Analysis: Navigating the Healthcare Sector with a 10.65% Upside - DirectorsTalk Interviews
Piper Sandler upgrades Teleflex stock rating on synergy potential - Investing.com
TFX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Teleflex Inc. stock underperforms Friday when compared to competitors - MarketWatch
Teleflex Urology Data Highlights Outcome Gains And Raises Valuation Questions - Yahoo Finance
Teleflex prices $500M senior notes offering to refinance debt - MSN
TFX Technical Analysis & Stock Price Forecast - Intellectia AI
Teleflex Inc. stock (US8793691069): Q1 2026 beat and upcoming earnings keep focus on NYSE-listed med - AD HOC NEWS
Teleflex Prices $500 Million Senior Notes for Refinancing - The Globe and Mail
Latham & Watkins Advises on Teleflex Incorporated’s US$500 Million Senior Notes Offering - Latham & Watkins LLP
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Incorporated announces pricing of senior notes - Medical Buyer
Teleflex prices $500M 5.875% notes due 2032 to fund redemption of 2027 notes - TradingView
Teleflex Is Not Just Restructuring — Here’s Why 2027 Could Matter! - Smartkarma
Teleflex launches $500 million senior notes offering - Investing.com UK
Teleflex Prices $500 Million of 2032 Senior Notes - Moomoo
Teleflex prices $500 million senior notes offering at 5.875% By Investing.com - Investing.com Nigeria
Teleflex Begins Private Offering of $500 Million Senior Notes - Moomoo
Teleflex (NYSE: TFX) to issue $500.0M 5.875% notes to refinance 2027 debt - Stock Titan
Teleflex Incorporated Announces Pricing Of $500 Million Senior Notes Offering - TradingView
Teleflex prices $500 million senior notes offering at 5.875% - Investing.com UK
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering - Teleflex
Teleflex (TFX) Launches $500M Senior Notes Offering to Refinance Debt - GuruFocus
Teleflex announces $500M private notes offering - MassDevice
TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank - TradingView
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.68%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):